AtriCure Inc. is a AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation.
AtriCure Inc. (ATRC) had a good day on the market for Monday November 23 as shares jumped 1.84% to close at $43.24. About 379,643 shares traded hands on 5,630 trades for the day, compared with an average daily volume of n/a shares out of a total float of 45.02 million. After opening the trading day at $42.94, shares of AtriCure Inc. stayed within a range of $43.84 to $42.15.
With today’s gains, AtriCure Inc. now has a market cap of $1.95 billion. Shares of AtriCure Inc. have been trading within a range of $51.76 and $23.17 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation. Its products line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offer a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
AtriCure Inc. is based out of Mason, OH and has some 730 employees. Its CEO is Michael H. Carrel.